Skip to main content
    B

    Bristol-Myers Squibb Company (BMY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $62.93
    -0.50 (-0.79%)

    Market Cap: $128.63B

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Bristol-Myers Squibb Company (BMY) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Bristol-Myers Squibb Company (BMY) has a latest price of $62.93 on Nov 17, 2026, 7.4% below its 52-week high of $67.94. Its price rose 32.3% over the past 12 months. The month-end price rose 22.7% over the 10 years through Oct 2026, a compound annual rate of 2.1%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $80.28 in Nov 2022 and its lowest $41.09 in May 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BMY with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BMY.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 3.7%, and over 6 months it rose 12.1%. The month-end price rose 21.2% over the 3 years through Oct 2026, a compound annual rate of 6.6%.

    PeriodChange
    1 month+5.3%
    3 months-3.7%
    6 months+12.1%
    12 months+32.3%
    12 months, with dividends+37.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+21.2%+6.6%
    5 years+7.0%+1.4%
    10 years+22.7%+2.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 23.5%, and its weakest was 2023, when it fell 28.7%.

    YearCloseChange
    2026 through Oct 2026$62.48+15.8%
    2025$53.94-4.6%
    2024$56.56+10.2%
    2023$51.31-28.7%
    2022$71.95+15.4%
    2021$62.35+0.5%
    2020$62.03-3.4%
    2019$64.19+23.5%
    2018$51.98-15.2%
    2017$61.28+4.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.2% above its 50-day average of $61.59 and 5.5% above its 200-day average of $59.63.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$62.93
    52-week high$67.94-7.4%
    52-week low$43.34+45.2%
    50-day average$61.59+2.2%
    200-day average$59.63+5.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 30.7%.

    MeasureValue
    1-year beta0.23
    Largest fall, 1 year-15.9%
    Largest fall, 3 years-30.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Bristol-Myers Squibb Company traded at 8.8x earnings at the end of 2025, against a 5-year median of 9.2x and a 10-year median of 10.2x.

    BMY valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BMY

    What is BMY's 1-year price change?

    Bristol-Myers Squibb Company's price rose 32.3% over the past 12 months. With dividends included, the 12-month total return was 37.6%.

    What is BMY's 5-year price change?

    Bristol-Myers Squibb Company's month-end price rose 7.0% over the 5 years through Oct 2026, a compound annual rate of 1.4%. These figures leave out dividends.

    What is BMY's 52-week high and low?

    Bristol-Myers Squibb Company's 52-week high is $67.94 and its 52-week low is $43.34. Its latest price of $62.93 on Nov 17, 2026 is 7.4% below the high.

    What is BMY's beta?

    Bristol-Myers Squibb Company's 1-year beta against the S&P 500 is 0.23, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 15.9%.

    Is the BMY chart free?

    Yes. Advanced Charting for BMY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.